In October, Oklahoma-based journalist and mom Juliana Keeping traveled to Boston with her son to confront Jeffrey Leiden, the CEO of Vertex Pharmaceuticals. Keeping’s son, Eli, has cystic fibrosis, and she’s not happy that Vertex’s two-drug combo, Orkambi, costs $259,000 a year. So Keeping, who gathered more than 124,700 signatures on, presented four members of Leiden’s team with the petition, which reads simply, “Stop price gouging our charity-funded drugs.”

Read More


Bluetooth-enabled tech shows promise for adherence in Cystic Fibrosis treatment


Thank YOU! This research is complete!